ROI Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,976
Closed -$473K 72
2025
Q2
$473K Sell
5,976
-4,085
-41% -$325K 0.3% 48
2025
Q1
$903K Sell
10,061
-2,882
-22% -$269K 0.66% 33
2024
Q4
$1.29M Sell
12,943
-1,653
-11% -$170K 0.88% 30
2024
Q3
$1.66M Buy
14,596
+837
+6% +$99.4K 1.14% 25
2024
Q2
$1.7M Buy
13,759
+337
+3% +$43.4K 1.24% 21
2024
Q1
$1.77M Sell
13,422
-298
-2% -$36.7K 1.39% 21
2023
Q4
$1.5M Buy
+13,720
New +$1.42M 1.24% 25

Other funds holding MRK

ROI Financial Advisors's MRK Position: Q3 2025 in Review

ROI Financial Advisors sold out of Merck (MRK) in Q3 2025, closing a stake of 5,976 shares — an estimated $473K sold.

ROI Financial Advisors first reported a position in MRK in Q4 2023 and held it in 7 quarters. The position peaked at $1.77M in Q1 2024. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • ROI Financial Advisors reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • ROI Financial Advisors sold 5,976 Merck shares in Q3 2025, an estimated $473K.
  • ROI Financial Advisors first reported a position in Merck in Q4 2023 and held it in 7 quarters.
  • ROI Financial Advisors's Merck position peaked at $1.77M in Q1 2024.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on ROI Financial Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.